Heavy chain antibodies binding to CD19
US12202898B2 · kind B2 · utility
0Cited by
12References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2019 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | May 4, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/569
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-CD19 heavy chain antibodies (e.g., UniAbs™) are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B cell disorders that are characterized by the expression of CD19.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.